GENOME ANNOUNCEMENT
===================

*Bordetella pertussis* is the main causative agent of whooping cough, or pertussis, a disease of the respiratory tract that is especially severe for infants. It is estimated that in 2010 pertussis resulted in 81,400 (CI 3,000 to 399,000) deaths, mainly in children ([@B1]). In the 1990s a resurgence of pertussis was observed in many vaccinated populations. Several causes may have contributed to this phenomenon, including increased awareness, low vaccine coverage, waning immunity, the switch from whole-cell vaccines to acellular vaccines, and pathogen adaptation ([@B2]). Studies of *B. pertussis* populations have identified two lineages that have predominated in the last 50 years, characterized by the alleles for the pertussis toxin promoter (*ptxP*) and the pertussis toxin A subunit (*ptxA*) ([@B3][@B4][@B6]). Strains with the genotype *ptxP1*-*ptxA1*, predominated in the period 1960--1990. These strains were replaced by strains with the genotype *ptxP3*-*ptxA1* in the 1990s, in a global selective sweep. Here we present the complete, closed, and annotated genome sequences of the isolates B1920 and B1917, which are representatives of the *ptxP1*-*ptxA1* and *ptxP3*-*ptxA1* lineages, respectively. Both strains were isolated from Dutch patients in 2000. Unannotated contigs of these strains, generated by 454 reads, were submitted previously ([@B7]). We believe that the B1917 and B1920 strains are more suitable reference strains than the Tohama I strain, which is now widely used ([@B7]). The Tohama I strain has been subcultured since the 1950s and is phylogenetically relatively distant from currently circulating strains ([@B8]).

Strains were grown on Bordet-Gengou agar supplemented with 15% sheep's blood and incubated for 3 days at 35°C. Genomic DNA was isolated using a QIAGEN Genomic-tip 100/G kit (Qiagen, Hilden, Germany) according to the manufacturer's instructions for Gram-negative bacteria, and a 10-kb library was prepared. Sequencing was performed using PacBio RS system using 6 SMRT cells per genome. The generated sequences were *de novo* assembled with HGAP ([@B9]) and trimmed and rotated by hand, resulting in a single, circular contig for both genomes. *B. pertussis* genomes are highly similar and therefore RATT ([@B10]) was used to transfer annotations from the *B. pertussis* reference genomes Tohama I, CS, and 18323 ([@B8], [@B11]). Subsequently, sequenced genomes were manually checked for genes not present in the reference genomes. The complete genome of *B. pertussis* B1917 comprises 4,102,186 bp and contains 3,820 genes, including 361 pseudogenes and 277 transposase genes. The complete genome of *B. pertussis* B1920 comprises 4,114,630 bp and harbors 3,827 genes, including 365 pseudogenes and 284 transposase genes. Both genomes contain 51 tRNA genes and 3 rRNA operons. A comparison of both genomes revealed three large inversions, a large deletion of 19 and 16 genes from *B. pertussis* B1917 and B1920, respectively, 29 small insertion or deletion events, and 223 single nucleotide polymorphisms.

Nucleotide sequence accession numbers. {#h1}
--------------------------------------

The whole-genome sequences have been deposited in DDBJ/ENA/GenBank under the accession numbers [CP009751](CP009751) and [CP009752](CP009752) for *B. pertussis* B1917 and B1920, respectively. The versions described in this paper are the first versions.
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